Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREMELIMUMAB vs TREPROSTINIL DIOLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TREMELIMUMAB vs TREPROSTINIL DIOLAMINE: Safety Overview

Metric TREMELIMUMAB TREPROSTINIL DIOLAMINE
Total FAERS Reports 2,387 250
Deaths Reported 594 40
Death Rate 24.9% 16.0%
Hospitalizations 1,510 136
Average Patient Age 64.7 yrs 55.7 yrs
% Female Patients 31.6% 79.2%
FDA Approval Date N/A Dec 20, 2013
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route INTRAVENOUS N/A
Marketing Status N/A Prescription